Adjuvant tamoxifen: 5 year control of dormant disease?

This publication has 5 references indexed in Scilit:

• Treatment of disease-negative but mucin-like carcinoma-associated antigen-positive breast cancer patients with tamoxifen: preliminary results of a prospective controlled randomized trial
  Cancer Chemotherapy and Pharmacology, 1994
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
  The Lancet, 1992
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Serial serum MCA measurements in the follow-up of breast cancer patients
  European Journal of Cancer and Clinical Oncology, 1991
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989